These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 23045311)

  • 1. [Treatment outcome of immune thrombocytopenia].
    Iványi JL; Marton E; Plander M
    Orv Hetil; 2012 Oct; 153(41):1613-21. PubMed ID: 23045311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy.
    Pamuk GE; Pamuk ON; Başlar Z; Ongören S; Soysal T; Ferhanoğlu B; Aydin Y; Ulkü B; Aktuğlu G; Akman N
    Ann Hematol; 2002 Aug; 81(8):436-40. PubMed ID: 12224000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up analysis after rituximab salvage therapy in adult patients with immune thrombocytopenia.
    Zaja F; Volpetti S; Chiozzotto M; Puglisi S; Isola M; Buttignol S; Fanin R
    Am J Hematol; 2012 Sep; 87(9):886-9. PubMed ID: 22718483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
    Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
    Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial.
    Ghanima W; Khelif A; Waage A; Michel M; Tjønnfjord GE; Romdhan NB; Kahrs J; Darne B; Holme PA;
    Lancet; 2015 Apr; 385(9978):1653-61. PubMed ID: 25662413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of idiopathic thrombocytopenic purpura (ITP) in patients with refractoriness to or with contraindication for corticosteroids and/or splenectomy with immunosuppressive therapy and danazol.
    Schiavotto C; Castaman G; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):29-34. PubMed ID: 8039755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter prospective study on the treatment of chronic idiopathic thrombocytopenic purpura.
    Dan K; Gomi S; Kuramoto A; Maekawa T; Nomura T
    Int J Hematol; 1992 Jun; 55(3):287-92. PubMed ID: 1498319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The choice of second-line therapy in steroid-resistant immune thrombocytopenia: role of platelet kinetics in a single-centre long-term study.
    Palandri F; Polverelli N; Catani L; Sollazzo D; Romano M; Levorato M; Vianelli N
    Am J Hematol; 2014 Nov; 89(11):1047-50. PubMed ID: 25103500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of platelet autoantibodies on the course of the disease and clinical response of patients with idiopathic thrombocytopenic purpura.
    Sikorska A; Konopka L; Maślanka K
    Int J Lab Hematol; 2008 Feb; 30(1):58-64. PubMed ID: 18190469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Childhood immune thrombocytopenia: role of rituximab, recombinant thrombopoietin, and other new therapeutics.
    Journeycake JM
    Hematology Am Soc Hematol Educ Program; 2012; 2012():444-9. PubMed ID: 23233617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dapsone salvage therapy for adult patients with immune thrombocytopenia relapsed or refractory to steroid and rituximab.
    Zaja F; Marin L; Chiozzotto M; Puglisi S; Volpetti S; Fanin R
    Am J Hematol; 2012 Mar; 87(3):321-3. PubMed ID: 22190262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence of treatments for adults with primary immune thrombocytopenia.
    George JN
    Am J Hematol; 2012 May; 87 Suppl 1():S12-5. PubMed ID: 22389032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective Evaluation of Survival and Prognostic Factors in Immune Thrombocytopenia: A Single-Center and Cross-Sectional Study.
    Pektaş G; Uncu İA; Dere Y; Öncü Ş; Kızılkaya MB; Sadi G; Pektaş MB
    Medicina (Kaunas); 2024 Jul; 60(7):. PubMed ID: 39064581
    [No Abstract]   [Full Text] [Related]  

  • 14. An analysis of outcomes and treatment costs for children undergoing splenectomy for chronic immune thrombocytopenia purpura.
    Gwilliam NR; Lazar DA; Brandt ML; Mahoney DH; Wesson DE; Mazziotti MV; Nuchtern JG; Lee TC
    J Pediatr Surg; 2012 Aug; 47(8):1537-41. PubMed ID: 22901913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Have splenectomy rate and main outcomes of ITP changed after the introduction of new treatments? A monocentric study in the outpatient setting during 35 years.
    Palandri F; Polverelli N; Sollazzo D; Romano M; Catani L; Cavo M; Vianelli N
    Am J Hematol; 2016 Jun; 91(4):E267-72. PubMed ID: 26799593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases.
    Vianelli N; Galli M; de Vivo A; Intermesoli T; Giannini B; Mazzucconi MG; Barbui T; Tura S; Baccaranion M;
    Haematologica; 2005 Jan; 90(1):72-7. PubMed ID: 15642672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of immune thrombocytopenic purpura in adults.
    Bussel J
    Semin Hematol; 2006 Jul; 43(3 Suppl 5):S3-10; discussion S18-9. PubMed ID: 16815346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reemergence of Splenectomy for ITP Second-line Treatment?
    Chater C; Terriou L; Duhamel A; Launay D; Chambon JP; Pruvot FR; Rogosnitzky M; Zerbib P
    Ann Surg; 2016 Nov; 264(5):772-777. PubMed ID: 27741009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Danazol therapy in patients with chronic idiopathic thrombocytopenic purpura: long-term results.
    Maloisel F; Andrès E; Zimmer J; Noel E; Zamfir A; Koumarianou A; Dufour P
    Am J Med; 2004 May; 116(9):590-4. PubMed ID: 15093754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results and prognostic factors of splenectomy in idiopathic thrombocytopenic purpura.
    Winde G; Schmid KW; Lügering N; Fischer R; Brandt B; Berns T; Bünte H
    J Am Coll Surg; 1996 Dec; 183(6):565-74. PubMed ID: 8957458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.